P-cadherin promotes liver metastasis and is associated with poor prognosis in colon cancer

American Journal of Pathology

Volumn 179, Issue 1, 2011, Pages 380-390

  Sun, Lichao ^a   Hu, Hai ^a   Peng, Liang ^a   Zhou, Zhuan ^a   Zhao, Xuan ^a   Pan, Jian ^a   Sun, Lixin ^a   Yang, Zhihua ^a   Ran, Yuliang ^a  

^a CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; MYC PROTEIN; P CADHERIN; SURVIVIN; UVOMORULIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER TISSUE; CELL MOTILITY; CELL PROLIFERATION; COLON CANCER; COLONY FORMATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR VOLUME; UPREGULATION; WOUND HEALING;

ANIMALS; APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CADHERINS; CELL PROLIFERATION; COLONIC NEOPLASMS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL;

EID: 80052435554     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.03.046     Document Type: Article

References (44)

1. D.A. Wicherts, R.J. de Haas, I.H. Borel Rinkes, E.E. Voest, and R. van Hillegersberg Better treatment for patients with colorectal liver metastases Ned Tijdschr Geneeskd 150 2006 345 351
2. H. Ochiai, Y. Nakanishi, Y. Fukasawa, Y. Sato, K. Yoshimura, Y. Moriya, Y. Kanai, M. Watanabe, H. Hasegawa, Y. Kitagawa, M. Kitajima, and S. Hirohashi A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases Oncology 75 2008 32 41
3. E.A. Bakalakos, J.A. Kim, D.C. Young, and E.W. Martin Jr Determinants of survival following hepatic resection for metastatic colorectal cancer World J Surg 22 1998 399 404
4. M.A. Choti, J.V. Sitzmann, M.F. Tiburi, W. Sumetchotimetha, R. Rangsin, R.D. Schulick, K.D. Lillemoe, C.J. Yeo, and J.L. Cameron Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 235 2002 759 766
5. P.D. Bos, X.H.F. Zhang, C. Nadal, W. Shu, R.R. Gomis, D.X. Nguyen, A.J. Minn, M.J. van de Vijver, W.L. Gerald, J.A. Foekens, and J. Massague Genes that mediate breast cancer metastasis to the brain Nature 459 2009 1005 1009
6. A.J. Minn, G.P. Gupta, P.M. Siegel, P.D. Bos, W. Shu, D.D. Giri, A. Viale, A.B. Olshen, W.L. Gerald, and J. Massague Genes that mediate breast cancer metastasis to lung Nature 436 2005 518 524
7. S.C. Smith, B. Nicholson, M. Nitz, H.F. Frierson Jr, M. Smolkin, G. Hampton, W. El-Rifai, and D. Theodorescu Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination Am J Pathol 174 2009 371 379
8. A. Ben-Ze'ev, and B. Geiger Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer Curr Opin Cell Biol 10 1998 629 639
9. F. Drees, S. Pokutta, S. Yamada, W.J. Nelson, and W.I. Weis α-Catenin is a molecular switch that binds E-cadherin-β-catenin and regulates actin-filament assembly Cell 123 2005 903 915
10. J.A. Jankowski, R. Bruton, N. Shepherd, and D.S. Sanders Cadherin and catenin biology represent a global mechanism for epithelial cancer progression Mol Pathol 50 1997 289 290
11. K. Hibi, T. Goto, H. Mizukami, Y.H. Kitamura, K. Sakuraba, M. Sakata, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, and Y. Sanada Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer Anticancer Res 29 2009 2215 2217
12. K. Hibi, Y.H. Kitamura, H. Mizukami, T. Goto, K. Sakuraba, M. Sakata, M. Saito, K. Ishibashi, G. Kigawa, H. Nemoto, and Y. Sanada Frequent CDH3 demethylation in advanced gastric carcinoma Anticancer Res 29 2009 3945 3947
13. J. Paredes, A. Albergaria, J.T. Oliveira, C. Jeronimo, F. Milanezi, and F.C. Schmitt P-cadherin overexpression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation Clin Cancer Res 11 2005 5869 5877
14. K. Taniuchi, H. Nakagawa, M. Hosokawa, T. Nakamura, H. Eguchi, H. Ohigashi, O. Ishikawa, T. Katagiri, and Y. Nakamura Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases Cancer Res 65 2005 3092 3099
15. J.A. Mandeville, B. Silva Neto, A.J. Vanni, G.L. Smith, K.M. Rieger-Christ, R. Zeheb, M. Loda, J.A. Libertino, and I.C. Summerhayes P-cadherin as a prognostic indicator and a modulator of migratory behaviour in bladder carcinoma cells BJU Int 102 2008 1707 1714
16. H. Hu, L. Sun, C. Guo, Q. Liu, Z. Zhou, L. Peng, J. Pan, L. Yu, J. Lou, Z. Yang, P. Zhao, and Y. Ran Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis Clin Cancer Res 15 2009 5485 5493
17. T.A. Patterson, E.K. Lobenhofer, S.B. Fulmer-Smentek, P.J. Collins, T.-M. Chu, W. Bao, H. Fang, E.S. Kawasaki, J. Hager, I.R. Tikhonova, S.J. Walker, L. Zhang, P. Hurban, F. de Longueville, J.C. Fuscoe, W. Tong, L. Shi, and R.D. Wolfinger Performance comparison of one-color and two-color platforms within the Microarray Quality Control (MAQC) project Nat Biotech 24 2006 1140 1150
18. Y. Guo, H. Guo, L. Zhang, H. Xie, X. Zhao, F. Wang, Z. Li, Y. Wang, S. Ma, J. Tao, W. Wang, Y. Zhou, W. Yang, and J. Cheng Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells J Virol 79 2005 14392 14403
19. A. Thakur, A. Bollig, J. Wu, and D.J. Liao Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice Mol Cancer 7 2008 11
20. C.C. Lee, M.S. Lee, H.C. Ho, S.K. Hung, Y.T. Tung, P. Chou, and Y.C. Su The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck Clin Chem Lab Med 47 2009 1277 1283
21. P. Fritz, E. Behrle, P. Beaune, M. Eichelbaum, and H.K. Kroemer Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase Histochemistry 99 1993 443 451
22. S.W. Pyo, M. Hashimoto, Y.S. Kim, C.H. Kim, S.H. Lee, K.R. Johnson, M.J. Wheelock, and J.U. Park Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome J Craniomaxillofac Surg 35 2007 1 9
23. Jager T, Becker M, Eisenhardt A, Tilki D, Totsch M, Schmid KW, Romics I, Rubben H, Ergun S, Szarvas T: The prognostic value of cadherin switch in bladder cancer. Oncol Rep 23:11251132
24. A. Milicic, L.A. Harrison, R.A. Goodlad, R.G. Hardy, A.M. Nicholson, M. Presz, O. Sieber, S. Santander, J.H. Pringle, N. Mandir, P. East, J. Obszynska, S. Sanders, E. Piazuelo, J. Shaw, R. Harrison, I.P. Tomlinson, S.A. McDonald, N.A. Wright, and J.A. Jankowski Ectopic expression of P-cadherin correlates with promoter hypomethylation early in colorectal carcinogenesis and enhanced intestinal crypt fission in vivo Cancer Res 68 2008 7760 7768
25. H.K. Williams, D.S. Sanders, J.A. Jankowski, G. Landini, and A.M. Brown Expression of cadherins and catenins in oral epithelial dysplasia and squamous cell carcinoma J Oral Pathol Med 27 1998 308 317
26. K. Gravdal, O.J. Halvorsen, S.A. Haukaas, and L.A. Akslen A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer Clinical Cancer Res 13 2007 7003 7011
27. M. Takeichi Cadherin cell adhesion receptors as a morphogenetic regulator Science 251 1991 1451 1455
28. K. Chu, C.J. Cheng, X. Ye, Y.C. Lee, A.J. Zurita, D.T. Chen, L.Y. Yu-Lee, S. Zhang, E.T. Yeh, M.C. Hu, C.J. Logothetis, and S.H. Lin Cadherin-11 promotes the metastasis of prostate cancer cells to bone Mol Cancer Res 6 2008 1259 1267
29. A. Sahni, M.T. Arevalo, S.K. Sahni, and P.J. Simpson-Haidaris The VE-cadherin binding domain of fibrinogen induces endothelial barrier permeability and enhances transendothelial migration of malignant breast epithelial cells Int J Cancer 125 2009 577 584
30. R.G. Hardy, C. Tselepis, J. Hoyland, Y. Wallis, T.P. Pretlow, I. Talbot, D.S.A. Sanders, G. Matthews, D. Morton, and J.A.Z. Jankowski Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon Gut 50 2002 513 519
31. V. Van Marck, C. Stove, K. Jacobs, G. Van den Eynden, and M. Bracke P-cadherin in adhesion and invasion: opposite roles in colon and bladder carcinoma Int J Cancer 128 2011 1031 1044
32. L.W. Cheung, P.C. Leung, and A.S. Wong Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer Oncogene 29 2010 2427 2440
33. T.J. Hugh, S.A. Dillon, G. O'Dowd, B. Getty, M. Pignatelli, G.J. Poston, and A.R. Kinsella β-Catenin expression in primary and metastatic colorectal carcinoma Int J Cancer 82 1999 504 511
34. W. Zhang, B. Jiang, Z. Guo, C. Sardet, B. Zou, C.S. Lam, J. Li, M. He, H.Y. Lan, R. Pang, I.F. Hung, V.P. Tan, J. Wang, and B.C. Wong Four-and-a-half LIM protein 2 promotes invasive potential and epithelial-mesenchymal transition in colon cancer Carcinogenesis 31 2010 1220 1229
35. C. Grandori, S.M. Cowley, L.P. James, and R.N. Eisenman The Myc/Max/Mad network and the transcriptional control of cell behavior Annu Rev Cell Dev Biol 16 2000 653 699
36. P.J. Kim, J. Plescia, H. Clevers, E.R. Fearon, and D.C. Altieri Survivin and molecular pathogenesis of colorectal cancer Lancet 362 2003 205 209
37. M. Zhang, J.J. Coen, Y. Suzuki, M.R. Siedow, A. Niemierko, L.Y. Khor, A. Pollack, Y. Zhang, A.L. Zietman, W.U. Shipley, and A. Chakravarti Survivin is a potential mediator of prostate cancer metastasis Int J Radiat Oncol Biol Phys 78 2010 1095 1103
38. M. Maeda, K.R. Johnson, and M.J. Wheelock Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition J Cell Sci 118 2005 873 887
39. Cheung LWT, Leung PCK, Wong AST: Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer. Oncogene 29:24272440
40. R. Kemler From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion Trends Genet 9 1993 317 321
41. A. Nagafuchi, and M. Takeichi Cell binding function of E-cadherin is regulated by the cytoplasmic domain EMBO J 7 1988 3679 3684
42. M. Dolled-Filhart, A. McCabe, J. Giltnane, M. Cregger, R.L. Camp, and D.L. Rimm Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome Cancer Res 66 2006 5487 5494
43. J. Behrens, J.P. von Kries, M. Kuhl, L. Bruhn, D. Wedlich, R. Grosschedl, and W. Birchmeier Functional interaction of β-catenin with the transcription factor LEF-1 Nature 382 1996 638 642
44. P.Y. Cheah, P.H. Choo, J. Yao, K.W. Eu, and F. Seow-Choen A survival-stratification model of human colorectal carcinomas with β-catenin and p27kip1 Cancer 95 2002 2479 2486